Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an update.
RaySearch Laboratories will publish its interim report for the first quarter of 2026 on April 29 at 7:30 a.m. CEST and will host a live webcast presentation at 11:00 a.m. the same day, where founder and CEO Johan Löf and CFO Nina Grönberg will present and comment on the results in English.
The webcast, which will include a Q&A session, is aimed at investors and other stakeholders, with presentation materials, the report, and a recording to be made available on the company’s website, underscoring RaySearch’s ongoing focus on transparency and engagement with the capital market.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Stockholm-based medical technology company specializing in software for improved cancer treatment. Its portfolio includes the RayStation treatment planning system, the RayCare oncology information system, the RayIntelligence oncology analytics platform, and the RayCommand treatment control system, used by nearly 1,200 clinics in 51 countries.
Average Trading Volume: 183,511
Technical Sentiment Signal: Buy
Current Market Cap: SEK7.68B
See more data about RAY.B stock on TipRanks’ Stock Analysis page.